Anika Therapeutics to Present at the Canaccord Genuity Musculoskeletal
Conference on March 19
Presentation to be Webcast Live at 3:30 p.m. ET / 2:30 p.m. CT
BEDFORD, Mass. -- March 13, 2013
Anika Therapeutics, Inc. (Nasdaq: ANIK) a leader in products for tissue
protection, healing and repair, based on hyaluronic acid (“HA”) technology,
today announced that Chief Executive Officer Dr. Charles Sherwood will be
presenting at the Canaccord Genuity Musculoskeletal Conference on Tuesday,
March 19, 2013 at 3:30 p.m. ET / 2:30 p.m. CT. The conference is being held at
the Westin Michigan Avenue in Chicago.
An audio webcast of the presentation will be available live and may be
accessed via the “Investor Relations” section of Anika’s website at
www.anikatherapeutics.com. An archive of the presentation also will be
available on the website.
About Anika Therapeutics, Inc.
Headquartered in Bedford, Mass., Anika Therapeutics, Inc. develops,
manufactures and commercializes therapeutic products for tissue protection,
healing, and repair. These products are based on hyaluronic acid (HA), a
naturally occurring, biocompatible polymer found throughout the body. Anika’s
products range from orthopedic/joint health solutions led by Orthovisc^®, a
treatment for osteoarthritis of the knee; to surgical aids in the ophthalmic
and anti-adhesion fields. The company also offers aesthetic dermal fillers for
the correction of facial wrinkles. Anika’s Italian subsidiary, Anika
Therapeutics S.r.l, provides complementary HA products in orthopedic/joint
health and anti-adhesion, as well as therapeutics in areas such as advanced
wound treatment and ear, nose and throat care. Its regenerative tissue
technology advances Anika’s vision to offer therapeutic products that go
beyond pain relief to protect and restore damaged tissue.
Anika Therapeutics, Inc.
Charles H. Sherwood, Ph.D., 781-457-9000
President and CEO
Press spacebar to pause and continue. Press esc to stop.